Last reviewed · How we verify

budesonide and montelukast

Romaker & Associates · FDA-approved active Small molecule Quality 5/100

budesonide and montelukast is a Small molecule drug developed by Romaker & Associates. It is currently FDA-approved.

At a glance

Generic namebudesonide and montelukast
SponsorRomaker & Associates
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about budesonide and montelukast

What is budesonide and montelukast?

budesonide and montelukast is a Small molecule drug developed by Romaker & Associates.

Who makes budesonide and montelukast?

budesonide and montelukast is developed and marketed by Romaker & Associates (see full Romaker & Associates pipeline at /company/romaker-associates).

What development phase is budesonide and montelukast in?

budesonide and montelukast is FDA-approved (marketed).

Related